Carleigh Krubiner and Ruth Faden‚ from Johns Hopkins University in the US‚ said there was a desperate need to “protect women through research‚ not just from research”

Quick Read

The widely accepted principle that mums-to-be are a ‘vulnerable’ group unfairly excludes them from taking part in clinical studies, and perpetuates the knowledge void around the impact of drugs taken during pregnancy, conclude researchers in the Journal of Medical Ethics. In a linked Commentary, Drs Carleigh Krubiner and Ruth Faden, of the Berman Institute, argue that the designation of pregnant women as ‘vulnerable’ “is inappropriate and disrespectful.”

Quick Read

…Instead of pursuing the traditional routes for treatment—surgery, radiation, and chemotherapy—she spent two weeks at a private clinic in Tijuana, which offered a variety of treatments rarely administered in the United States: a compound known as cesium carbonate, infusions of vitamin C, a variety of immune boosters, and the drug Laetrile, sometimes referred to as vitamin B-17, which was declared illegal by the FDA

Quick Read

Little is known about how pregnant women respond to most drugs. The Second Wave Initiative was launched to respond to this problem.

Read More